So Yeon Oh

644 total citations
40 papers, 375 citations indexed

About

So Yeon Oh is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, So Yeon Oh has authored 40 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in So Yeon Oh's work include Gastric Cancer Management and Outcomes (6 papers), Pain Management and Opioid Use (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). So Yeon Oh is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Pain Management and Opioid Use (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). So Yeon Oh collaborates with scholars based in South Korea, Ethiopia and United States. So Yeon Oh's co-authors include Bhumsuk Keam, Dae Seog Heo, Dong‐Wan Kim, Tae Min Kim, Keun‐Wook Lee, Jee Hyun Kim, Jong Seok Lee, Kwonoh Park, Jin‐Hyeok Hwang and Soo‐Mee Bang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

So Yeon Oh

35 papers receiving 366 citations

Peers

Countries citing papers authored by So Yeon Oh

Since Specialization

Citations

This map shows the geographic impact of So Yeon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by So Yeon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites So Yeon Oh more than expected).

Fields of papers citing papers by So Yeon Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by So Yeon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by So Yeon Oh. The network helps show where So Yeon Oh may publish in the future.

Co-authorship network of co-authors of So Yeon Oh

This figure shows the co-authorship network connecting the top 25 collaborators of So Yeon Oh. A scholar is included among the top collaborators of So Yeon Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with So Yeon Oh. So Yeon Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial 2025 ·Cancer Research and Treatment ·(unknown), (unknown), Min Kyoung Kim, Keon Uk Park, Tak Yun, Keun‐Wook Lee, Joo Hang Kim, Bhumsuk Keam, Byoung Chul Cho, So Yeon Oh, Sang‐Hee Cho, Sangwoo Kim, Sung‐Bae Kim, Min Hee Hong, Hye Ryun Kim	1
2	Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4) 2025 ·Cancer Research and Treatment ·Yoon‐Koo Kang, Min‐Hee Ryu, Do‐Youn Oh, Sang Cheul Oh, Sun Young Rha, Keun‐Wook Lee, Ik Joo Chung, Sung Yong Oh, Sun Jin Sym, Won Ki Kang, Jong Gwang Kim, Byoung Yong Shim, Inho Kim, Jin Young Kim, Eun‐Kee Song, Hyo Jin Lee, Seok Yun Kang, Dong‐Hoe Koo, So Yeon Oh	0
3	A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) 2024 ·ESMO Open ·Eun Joo Kang, Yaewon Yang, Sang-Ho Lee, Yu Jung Kim, Seungtaek Lim, (unknown), Yoon Ji Choi, Yong Jae Lee, Tae Min Kim, (unknown), Hee Kyung Ahn, (unknown), (unknown), So Yeon Oh, Woo Kyun Bae, Han Suk Ryu, Kang Hyun Park, KK Lee	2
4	ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17). 2024 ·Journal of Clinical Oncology ·Yaewon Yang, Eun Joo Kang, (unknown), Yu Jung Kim, (unknown), Myung‐Ju Ahn, Youngjoo Lee, (unknown), Il Hwan Kim, Hee Kyung Ahn, (unknown), So Yeon Oh, (unknown), Hyewon Ryu, Kyong Hwa Park, Ki Hyeong Lee	1
5	Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma 2024 ·Anticancer Research ·Hwan Hee Lee, So Yeon Oh, Hyojeung Kang, (unknown)	1
6	A Prospective, Single-Cohort, Open, Multi-center, Observational Study of Sublingual Fentanyl for Breakthrough Cancer Pain: Effectiveness, Safety, and Tolerability in Korean Cancer Patients 2024 ·Cancer Research and Treatment ·Youn Seon Choi, Su-Jin Koh, Woo Kyun Bae, Se Hyung Kim, Seong Hoon Shin, So Yeon Oh, Sang Byung Bae, Yaewon Yang, Eun‐Kee Song, Yoon Young Cho, Pyung Bok Lee, (unknown), Min‐Young Lee, Jin Seok Ahn	0
7	Lossless Immunocytochemistry Based on Large-Scale Porous Hydrogel Pellicle for Accurate Rare Cell Analysis 2023 ·ACS Applied Materials & Interfaces ·(unknown), Seung‐Hoon Kim, (unknown), Taehoon Kim, Sooyeol Kim, (unknown), Jae Young Kim, Seung Joon Lee, Young Zoon Kim, So Yeon Oh, Ji Hyae Lim, Hyun Mee Ryu, Minseok S. Kim	3
8	Fully Automated Continuous Centrifugal Microfluidics Isolates Natural Killer Cells with High Performance and Minimal Stress 2023 ·Analytical Chemistry ·(unknown), Seung‐Hoon Kim, (unknown), (unknown), (unknown), Min Young Kim, (unknown), (unknown), So Yeon Oh, Sun‐Young Kong, Young Zoon Kim, Jae Young Joung, Minseok S. Kim	7
9	A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas 2023 ·Cancer ·Jiyun Lee, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Seyoung Seo, (unknown), JW Kim, (unknown), Eun Joo Kang, Ju Won Kim, Yoon Ji Choi, Byoung Yong Shim, (unknown), Lee Chun Park, Seong Hoon Shin, Jae‐Joon Kim, So Yeon Oh, Min Kyoung Kim, Myung‐Ju Ahn	9
10	Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer 2021 ·Oncology ·(unknown), (unknown), Dong Il Kim, Seungju Lee, (unknown), (unknown), Jae‐Joon Kim, So Yeon Oh, Ji Hyeon Joo, (unknown)	3
11	Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment 2021 ·Scientific Reports ·So Yeon Oh, (unknown), Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo	85
12	Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study 2020 ·Cancer Research and Treatment ·Eun Ju Park, Kwonoh Park, Jae‐Joon Kim, (unknown), Ki Sun Jung, So Yeon Oh, Yun Jeong Hong, (unknown), (unknown), (unknown)	13
13	Effect of education on preference of parenteral nutrition for patients in palliative care unit: quantitative and qualitative study with an anthropological approach 2020 ·Annals of Palliative Medicine ·(unknown), So Yeon Oh, (unknown), (unknown), Kwonoh Park, (unknown), Jae‐Joon Kim, Eunju Park	3
14	Interference with daily functioning by breakthrough pain in patients with cancer 2020 ·Supportive Care in Cancer ·Jung Hun Kang, Su‐Jin Koh, So Yeon Oh, Rock Bum Kim, Seong Hoon Shin, Yun‐Gyoo Lee, Bong-Seog Kim, Hun Mo Ryoo, So Young Yoon, Joung Soon Jang, (unknown), Young Jin Choi, Moon Hee Lee, Kyung‐Hee Lee	11
15	Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer 2018 ·Cancer Research and Treatment ·Jin Won Kim, Jong Gwang Kim, Byung Woog Kang, Ik-Joo Chung, Young Seon Hong, Tae‐You Kim, Hong Song, Kyung Hee Lee, Dae Young Zang, Yoon Ho Ko, Eun‐Kee Song, Jin Ho Baek, Dong‐Hoe Koo, So Yeon Oh, Hanna Cho, Keun‐Wook Lee	14
16	Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study 2016 ·Supportive Care in Cancer ·Kwonoh Park, (unknown), So Yeon Oh	18
17	Evans syndrome following long-standing Hashimoto's thyroiditis and successful treatment with rituximab 2011 ·The Korean Journal of Hematology ·Hye Jin Oh, (unknown), (unknown), (unknown), So Yeon Oh, In Sook Sohn	9
18	Central Pontine Myelinolysis in a Patient with Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation: A Case Report 2008 ·Journal of Korean Medical Science ·(unknown), (unknown), (unknown), Ki Hwan Kim, Jinwon Kim, Jiyoung Rhee, Hye Jin Kim, Hyeon Gyu Yi, So Yeon Oh, Joo Han Lim, Sae‐Won Han, Sang Yoon Lee, Inho Kim, Sung‐Soo Yoon, Seonyang Park, Byoung Kook Kim	7
19	Venous thromboembolism in patients with pancreatic adenocarcinoma: Lower incidence in Asian ethnicity 2008 ·Thrombosis Research ·So Yeon Oh, Jee Hyun Kim, Keun‐Wook Lee, Soo‐Mee Bang, Jin‐Hyeok Hwang, Doyeun Oh, Jong Seok Lee	49
20	P3-140: Erlotinib treatment after progression on gefitinib in non-small cell lung cancer(NSCLC) 2007 ·Journal of Thoracic Oncology ·Sung Hoon Sim, Sae‐Won Han, So Yeon Oh, (unknown), Yu Jung Kim, Se‐Hoon Lee, Dong‐Wan Kim, Dae Seog Heo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact